Healthpeak Properties (NYSE:DOC) Stock: Insider Ankit Patadia Sells 6,115 Shares

Key Points

• Insider sale: EVP Ankit Patadia sold 6,115 Healthpeak shares for about $127,070, reducing his ownership by 68.3% to 2,838 shares.
• Quarterly results were mixed: Healthpeak reported EPS of $0.02, below the $0.43 consensus, while revenue of $820.9 million exceeded estimates and rose 16.3% year over year.
• Dividend and analyst view: The company announced a monthly dividend of $0.1017 per share, equivalent to a 5.9% yield. Analysts’ consensus rating was Hold, with an average price target of $21.47.

Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) EVP Ankit Patadia sold 6,115 shares of the stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $20.78, for a total value of $127,069.70. Following the completion of the sale, the executive vice president owned 2,838 shares in the company, valued at approximately $58,973.64. The trade was a 68.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Healthpeak Properties Trading Up 2.0%

Shares of DOC stock traded up $0.41 on Monday, reaching $20.67. 5,740,541 shares of the company's stock were exchanged, compared to its average volume of 7,671,011. Healthpeak Properties, Inc. has a 52 week low of $15.70 and a 52 week high of $22.95. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.87. The stock has a market capitalization of $14.25 billion, a PE ratio of 38.27, a P/E/G ratio of 2.50 and a beta of 1.01. The company's fifty day simple moving average is $19.74 and its 200 day simple moving average is $19.20.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Monday, November 2nd. The real estate investment trust reported $0.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.43 by ($0.41). Healthpeak Properties had a net margin of 12.32% and a return on equity of 4.04%. The business had revenue of $820.89 million for the quarter, compared to analysts' expectations of $739.18 million. During the same quarter in the previous year, the firm earned $0.46 EPS. Healthpeak Properties's revenue was up 16.3% compared to the same quarter last year. As a group, analysts forecast that Healthpeak Properties, Inc. will post 1.77 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 18th will be paid a dividend of $0.1017 per share. This represents a $1.22 dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date of this dividend is Friday, December 18th. Healthpeak Properties's payout ratio is currently 225.93%.

Analyst Ratings Changes

Several research firms recently commented on DOC. Cantor Fitzgerald reduced their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set a "neutral" rating on the stock in a research note on Wednesday, November 4th. Wells Fargo & Company lowered their price objective on shares of Healthpeak Properties from $22.00 to $19.00 and set an "equal weight" rating for the company in a research report on Monday, October 19th. Jefferies Financial Group initiated coverage on shares of Healthpeak Properties in a research note on Tuesday, September 15th. They issued a "hold" rating and a $21.00 target price on the stock. Barclays dropped their target price on shares of Healthpeak Properties from $24.00 to $21.00 and set an "equal weight" rating on the stock in a research note on Tuesday, October 13th. Finally, Citigroup raised their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock a "neutral" rating in a research report on Tuesday, August 11th. Four analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $21.47.

Institutional Investors Weigh In On Healthpeak Properties

Hedge funds have recently made changes to their positions in the company. Pension & Wealth Management Advisors Inc. purchased a new stake in Healthpeak Properties in the third quarter valued at approximately $27,000. Clearstead Trust LLC raised its position in Healthpeak Properties by 66.7% during the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust's stock worth $29,000 after buying an additional 543 shares during the last quarter. Security National Bank of SO Dak purchased a new position in Healthpeak Properties during the 2nd quarter worth approximately $32,000. Latitude Advisors LLC purchased a new position in Healthpeak Properties during the 3rd quarter worth approximately $34,000. Finally, Markowski Investments acquired a new stake in Healthpeak Properties during the 2nd quarter valued at approximately $38,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust that owns and operates properties serving the healthcare and life sciences industries. Its portfolio includes outpatient medical buildings, life science facilities and senior housing communities.

The company's properties are located across the United States, with investments in major healthcare and life science markets. In 2024, Healthpeak completed its merger with Physicians Realty Trust, expanding its portfolio of outpatient medical properties.

Based in Denver, Colorado, Healthpeak traces its history to a healthcare property company founded in 1985.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.